Physician profile
Trina R Kaiser
NPI 1861474017
$4,997.53
in general payments reported to CMS, 2019-2025
16 companies · $1,713 in 2025
The $1,713 reported for 2025 was more than what 92% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $265 · 2022: $296 · 2023: $546 · 2024: $2,178 · 2025: $1,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,265 · Food and Beverage: $2,172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,264.86 |
| Food and Beverage | $2,171.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,015.44 | 2021-2025 | Intracept, Wavewriter Alpha Prime 16, Patient Trial Kit |
| Abbvie INC. | $1,056.23 | 2021-2025 | |
| Pfizer INC. | $222.11 | 2023-2025 | |
| Nevro Corp. | $142.10 | 2024 | Senza |
| Allergan, INC. | $108.92 | 2021-2022 | |
| Medtronic, INC. | $105.77 | 2021-2024 | Inceptiv |
| Lundbeck LLC | $67.76 | 2023-2025 | Vyepti |
| Grt US Holding, INC. | $62.10 | 2021-2022 | |
| Relievant Medsystems, INC. | $46.56 | 2023 | Intracept |
| Averitas Pharma INC. | $44.40 | 2023-2024 | Qutenza |
| Vertos Medical, INC. | $33.94 | 2024 | Mild Device Kit |
| Globus Medical, INC. | $27.00 | 2025 | Senza |
| Vertex Pharmaceuticals Incorporated | $18.68 | 2025 | |
| Lilly USA, LLC | $17.30 | 2021 | |
| Abbott Laboratories | $15.66 | 2023 | Freestyle Libre 3 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trina Kaiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.